A case of successful treatment of a female patient with ALK-positive inflammatory myofibroblastic tumor of the greater omentum
J. M. Madyarov,
A. V. Polynovskiy,
I. Sh. Tatayev,
S. N. Berdnikov,
K. S. Petrov,
Z. R. Rasulov,
A. E. Kulikov,
A. O. Rasulov https://doi.org/10.17650/2782-3202-2021-1-1-43-49
Abstract
Inflammatory myofibroblastic tumors are a group of rare mesenchymal tumors which were considered by some authors to be benign; however, with accumulation of experience in treatment of these tumors their capability for invasive growth and metastasis was identified.
The literature review showed a small number of clinical cases with intraabdominal forms of inflammatory myofibroblastic tumors. Mostly these are patients with tumors of the liver, upper gastrointestinal tract, pancreatobiliary area, small and large intestines. It should be noted that the literature review didn’t present any cases of isolated tumors of the greater omentum, hence we’ve decided to present a detailed description of a clinical observation of a female patient with rare ALK-positive inflammatory myofibroblastic tumor of the greater omentum.
About the Authors
J. M. Madyarov
Oncology Center, Clinical Hospital “Lapino 2” of the “Mother and Child” Group of companies
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081, Russia
A. V. Polynovskiy
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Russian Federation
24 Kashirskoe Shosse, Moscow 115478, Russia
I. Sh. Tatayev
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Russian Federation
24 Kashirskoe Shosse, Moscow 115478, Russia
S. N. Berdnikov
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Russian Federation
24 Kashirskoe Shosse, Moscow 115478, Russia
K. S. Petrov
Radiology Department, Medscan LLC
Russian Federation
Russian Federation
121A Obrucheva St., Moscow 119421, Russia
Z. R. Rasulov
Oncology Center, Clinical Hospital “Lapino 2” of the “Mother and Child” Group of companies
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081, Russia
A. E. Kulikov
Oncology Center, Clinical Hospital “Lapino 2” of the “Mother and Child” Group of companies
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081, Russia
A. O. Rasulov
Oncology Center, Clinical Hospital “Lapino 2” of the “Mother and Child” Group of companies
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081, Russia
References
1. Umiker W.O., Iverson L. Postinflammatory tumors of the lung; report of four cases simulating xanthoma, fibroma, orplasmacell tumor. J Thorac Surg 1954;28(1):55–63.
2. Patnana M., Sevrukov А.B., Elsayes K.M. et al. Inflammatory Pseudotumor: The Great Mimicker. Am J Roentgenol 2012;198(3):W217–27. DOI: 10.2214/AJR.11.7288.
3. Dubova E.A., Pavlov K.A., Frank G.A., Schegolev A.I. Inflammatory myofibroblastic liver tumor. Arhiv patologii = Archive of Pathology 2009;3:25–8. (In Russ.).
4. Frank G.A. Problems of morphological classification and diagnosis of soft tissue tumors. Prakticheskaya onkologiya = Practical oncology 2004;5(4):231–6. (In Russ.).
5. Coffin C.M., Hornick J.L., Fletcher C.D. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 2007;31(4):509–20. DOI: 10.1097/01.pas.0000213393.57322.c7.
6. Gleason B.C., Hornick J.L. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol 2008;61(4):428–37. DOI: 10.1136/jcp.2007.049387.
7. Vassiliadis T., Vougiouklis N., Patsiaoura K. еt al. Inflammatory pseudotumor of the liver successfully treated with nonsteroidal antiinflammatory drugs: a challenge diagnosis for one not so rare entity. Eur J Gastroenterol Hepatol 2007;19(11):1016–20. DOI: 10.1097/MEG.0b013e32821acdd2.
8. Ihedioha U., Coldewey J., Murphy D. Inflammatory pseudotumor of the caecum: a case report. Scott Med J 2004;49(4):157–8. DOI: 10.1177/003693300404900415.
9. Pack G.T., Baker H.W. Total right hepatic lobectomy: report of a case. Ann Surg 1953;138(2):253–8. DOI: 10.1097/00000658-195308000-00012.
10. WHO Classification of tumours of soft tissue and bone. 4th edn. Ed by C.D.M. Fletcher, J.A. Bridge, P.C.W. Hogendoorn, F. Mertens. Lyon: IARC Press, 2013.
11. Coffin C.M., Watterson J., Priest J.R., Dehner L.P. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 1995;19(8):859–72. DOI: 10.1097/00000478-199508000-00001.
12. Bjelovic M., Micev M., Spica B. et al. Primary inflammatory myofibroblastic tumor of the stomach in an adult woman: a case report and review of the literature. World J Surg Oncol 2013;11:35. DOI: 10.1186/1477-7819-11-35.
13. Park S.H., Kim J.H., Min B.W. et al. Exophytic inflammatory myofibroblastic tumor of the stomach in an adult woman: a rare cause of hemoperitoneum. World J Gastroenterol 2008;14(1):136–9. DOI: 10.3748/wjg.14.136.
14. Arpacı E., Yetişyiğit T., Ulaş A. et al. A case of intraabdominal myofibroblastic tumor with aggressive behavior. Turk J Oncol 2010;25(1):28–32.
15. Ribeiro M.C., Lopes L.R., de Souza Neto J.C. et al. Rare gastric inflammatory myofibroblastic tumor in an adult woman: a case report with review of the literature. Case Rep Med 2012;4:1–4.
16. Shi H., Wei L., Sun L., Guo A. Primary gastric inflammatory myofibroblastic tumor: A clinicopathologic and immunohistochemical study of 5 cases. Pathol Res Pract 2010;206(5):287–91. DOI: 10.1016/j.prp.2009.09.002.
17. Kim S.J., Kim W.S., Cheon J.E. et al. Inflammatory myofibroblastic tumors of the abdomen as mimickers of malignancy: imaging features in nine children. Am J Roentgenol 2009;193(5):1419–24. DOI: 10.2214/AJR.09.2433.
18. Mirshemirani A., Tabari A.K., Sadeghian N. et al. Abdominal inflammatory myofibroblastic tumor: report on four cases and review of literature. Iran J Pediatr 2011;21(4):543–8.
19. Marie-Cardine A., Berrebi D., Orbach D. [Guidelines for management of localized inflammatory myofibroblastic tumours in children (In French)]. Bull Cancer 2011;98(2):209–16. DOI: 10.1684/bdc.2011.1311.
20. Renzing N., Ebsen M., Schwerk W. [Inflammatory pseudotumours of the liver associated with Crohn’s disease: a possible pitfall in contrast-enhanced ultrasound (In German)]. Z Gastroenterol 2011;49(7): 827–31. DOI: 10.1055/s-0029-1245979.
21. Xiang J., Liu X., Wu S. et al. Multiple inflammatory myofibroblastic tumor of the duodenum: case report and literature review. J Gastrointest Surg 2012;16(7):1442–5. DOI: 10.1007/s11605-012-1883-9.
22. Balabaud C., Bioulac-Sage P., Goodman Z.D., Makhlouf H.R. Inflammatory pseudotumor of the liver: a rare but distinct tumor-like lesion. Gastroenterol Hepatol (N Y) 2012;8(9):633–4.
23. Shah S.M., Sussman D., Jorda M., Ribeiro A. EUS with EMR of an inflammatory myofibroblastic tumor of the stomach. Gastrointest Endosc 2008;67(3):561–3. DOI: 10.1016/j.gie.2007.06.031.
24. Kwak J.W., Paik C.N., Jung S.H. et al. An inflammatory myofibroblastic tumor of the ampulla of vater successfully managed with endoscopic papillectomy: report of a case. Gut Liver 2010;4(3):419–22. DOI: 10.5009/gnl.2010.4.3.419.
25. Fong S.S., Zhao C., Yap W.M. et al. Inflammatory myofibroblastic tumour of the duodenum. Singapore Med J 2012;53(2):e28–31.
26. Wynn G.R., Giles A., Steger A.S., Wilkinson M.L. Case report: inflammatory myofibroblastic tumor of the duodenum. J Gastrointest Cancer 2008;39(1–4):79–81. DOI: 10.1007/s12029-008-9042-y.
27. Mattei P., Barnaby K. Rapid regression of duodenal inflammatory myofibroblastic tumor after intravenous ketorolac: case report and review of the literature. J Pediatr Surg 2008;43(6):1196–9. DOI: 10.1016/j.jpedsurg.2008.01.012.
28. Kim E.Y., Lee I.K., Lee Y.S. et al. Inflammatory myofibroblastic tumor in colon. J Korean Surg Soc 2012;82(1):45–9. DOI: 10.4174/jkss.2012.82.1.45.
29. Tao Y.L., Wang Z.J., Han J.G., Wei P. Inflammatory myofibroblastic tumor successfully treated with chemotherapy and nonsteroidals: A case report. World J Gastroenterol 2012;18(47):7100–3. DOI: 10.3748/wjg.v18.i47.7100.
30. Johnson K., Notrica D.M., Carpentieri D. et al. Successful treatment of recurrent pediatric inflammatory myofibroblastic tumor in a single patient with a novel chemotherapeutic regimen containing celecoxib. J Pediatr Hematol Oncol 2013;35(5):414–6. DOI: 10.1097/MPH.0b013e3182915cef.
31. Germanidis G., Xanthakis I., Tsitouridis I. et al. Regression of inflammatory myofibroblastic tumor of the gastrointestinal tract under infliximab treatment. Dig Dis Sci 2005;50(2):262–5. DOI: 10.1007/s10620-005-1593-1.
Review
For citations:
Madyarov J.M., Polynovskiy A.V., Tatayev I.Sh., Berdnikov S.N., Petrov K.S., Rasulov Z.R., Kulikov A.E., Rasulov A.O. A case of successful treatment of a female patient with ALK-positive inflammatory myofibroblastic tumor of the greater omentum. MD-Onco. 2021;1(1):43-49. (In Russ.) https://doi.org/10.17650/2782-3202-2021-1-1-43-49
Views:
424
Email this article 